ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Further, inhibiting both BCL-2 and BCR-ABL is sufficient to induce apoptosis in CML stem cells in a murine CML model and TKI-resistant BP-CML patient samples35.